Canlyniadau Chwilio - Gradl, Gabriele

Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons gan Gradl, Gabriele, Krieg, Eva-Maria, Schulz, Martin

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Comparing outpatient oral antibiotic use in Germany and the Netherlands from 2012 to 2016 gan Gradl, Gabriele, Teichert, Martina, Kieble, Marita, Werning, Johanna, Schulz, Martin

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Quality Appraisal of Ambulatory Oral Cephalosporin and Fluoroquinolone Use in the 16 German Federal States from 2014–2019 gan Gradl, Gabriele, Werning, Johanna, Enners, Salka, Kieble, Marita, Schulz, Martin

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Utilization of drugs with reports on potential efficacy or harm on COVID‐19 before, during, and after the first pandemic wave gan Enners, Salka, Gradl, Gabriele, Kieble, Marita, Böhm, Michael, Laufs, Ulrich, Schulz, Martin

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Wie wirken Generikaquoten? Eine Analyse am Beispiel der HIV-Infektion gan Rüsenberg, Robin, Baumgarten, Axel, Mauss, Stefan, Gradl, Gabriele, Schulz, Martin, Bartmeyer, Barbara, Kollan, Christian, Schmidt, Daniel

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany gan Moorkens, Evelien, Barcina Lacosta, Teresa, Vulto, Arnold G., Schulz, Martin, Gradl, Gabriele, Enners, Salka, Selke, Gisbert, Huys, Isabelle, Simoens, Steven

Cael y testun llawn Cael y testun llawn Cael y testun llawn